dc.contributor.author | Kamakia, Faith | |
dc.contributor.author | Stephen, Ouma | |
dc.contributor.author | Kagia, Richard | |
dc.date.accessioned | 2025-02-06T07:47:34Z | |
dc.date.available | 2025-02-06T07:47:34Z | |
dc.date.issued | 2024-01-12 | |
dc.identifier.uri | www.austinpublishinggroup.com | |
dc.identifier.uri | http://ir.kabarak.ac.ke/handle/123456789/1579 | |
dc.description.abstract | Pain alleviation is the primary intervention in promoting quality of life. Among the compounds used in management of pain are opioids. Codeine is mostly used as antitussive and is commonly present in cough syrups. Tramadol and Morphine are used as analgesics based on severity of pain. Although these drugs provide instant pain relief, they are associated with many side effects and the most worrying once are addiction, respiratory depression and tolerance. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Austin Journal of Pharmacology and Therapeutics | en_US |
dc.subject | Codeine | en_US |
dc.subject | Tramadol | en_US |
dc.subject | Morphine | en_US |
dc.subject | docking score | en_US |
dc.subject | wissADME | en_US |
dc.subject | Protox II | en_US |
dc.subject | toxicity | en_US |
dc.title | In Silico Screening of Compounds Similar to Codeine, Tramadol, and Morphine with Better Pharmacodynamic and Pharmacokinetics Profiles | en_US |
dc.type | Article | en_US |